Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Shares Outstanding (2018 - 2022)

China SXT Pharmaceuticals (SXTC) has 5 years of Shares Outstanding data on record, last reported at $2.0 million in Q1 2022.

  • For Q1 2022, Shares Outstanding rose 161.69% year-over-year to $2.0 million; the TTM value through Mar 2022 reached $2.0 million, up 161.69%, while the annual FY2022 figure was $22.8 million, 2834.32% up from the prior year.
  • Shares Outstanding reached $2.0 million in Q1 2022 per SXTC's latest filing, up from $776255.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $5.0 million in Q1 2018 and bottomed at $283834.0 in Q1 2019.
  • Average Shares Outstanding over 5 years is $1.7 million, with a median of $776255.0 recorded in 2021.
  • Peak YoY movement for Shares Outstanding: crashed 94.32% in 2019, then soared 161.69% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $5.0 million in 2018, then plummeted by 94.32% to $283834.0 in 2019, then soared by 52.68% to $433346.0 in 2020, then surged by 79.13% to $776255.0 in 2021, then surged by 161.69% to $2.0 million in 2022.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $2.0 million in Q1 2022, $776255.0 in Q1 2021, and $433346.0 in Q1 2020.